• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种 DRD2 基因多态性与年轻白种人患者急性和迟发性抗精神病药物诱发运动障碍的关联。

Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.

机构信息

Mental Health Organization GGZ Centraal, Amersfoort, the Netherlands.

出版信息

Psychopharmacology (Berl). 2012 Feb;219(3):727-36. doi: 10.1007/s00213-011-2394-1. Epub 2011 Jul 13.

DOI:10.1007/s00213-011-2394-1
PMID:21750899
Abstract

RATIONALE

Pharmacogenetic studies on antipsychotic-induced movement disorders (MD) in schizophrenia so far have focused mainly on tardive dyskinesia. Only a few examined the more acute antipsychotic-induced MD such as parkinsonism and akathisia. Notably, all MD relate to deregulation of the dopamine system.

OBJECTIVE

This study aimed to replicate previously reported associations in candidate genes for acute and tardive antipsychotic-induced MD in a young Caucasian sample.

METHODS

In 402 patients (median age 26 years), a total of 13 polymorphisms were genotyped in eight dopamine-related candidate genes selected a priori from the literature (regarding dopamine and serotonin receptors, dopamine degradation, and free radicals scavenging enzymes pathways).

RESULTS

Patients with MD used on average a higher haloperidol dose equivalent when compared to those without MD. The prevalence of MD was high and did not differ between first- and second-generation antipsychotics. Significant associations were found between (a) the TaqI_D polymorphism and akathisia (OR = 2.3, p = 0.001 for each extra C-allele) and (b) the -141C polymorphism and tardive dyskinesia (OR = 0.20, p = 0.001 for each extra Del allele). The other polymorphisms were not significantly associated with an MD.

CONCLUSIONS

Two associations were found between genetic variation TaqI_D and the -141C polymorphisms in the DRD2 gene and antipsychotic-induced MD; one with acute akathisia and one with tardive dyskinesia. These were previously reported to be associated with tardive dyskinesia and acute parkinsonism, respectively. These results suggest that the contribution of these DRD2 gene variants in the vulnerability of antipsychotic-induced MD takes place in a more general or pleiotropic way.

摘要

背景

迄今为止,抗精神病药引起的精神分裂症运动障碍(MD)的药物遗传学研究主要集中在迟发性运动障碍上。只有少数研究检查了更急性的抗精神病药引起的 MD,如帕金森病和静坐不能。值得注意的是,所有 MD 都与多巴胺系统的失调有关。

目的

本研究旨在在一个年轻的白种人群体中复制先前报道的候选基因与急性和迟发性抗精神病药引起的 MD 之间的关联。

方法

在 402 名患者(中位年龄 26 岁)中,总共对从文献中预先选择的八个与多巴胺相关的候选基因中的 13 个多态性进行了基因分型(涉及多巴胺和 5-羟色胺受体、多巴胺降解和自由基清除酶途径)。

结果

与无 MD 的患者相比,有 MD 的患者平均使用的氟哌啶醇剂量当量更高。MD 的患病率很高,并且在第一代和第二代抗精神病药之间没有差异。发现以下显著关联:(a)TaqI_D 多态性与静坐不能(每个额外的 C-等位基因的 OR=2.3,p=0.001)和(b)-141C 多态性与迟发性运动障碍(每个额外的 Del 等位基因的 OR=0.20,p=0.001)之间存在显著关联。其他多态性与 MD 没有显著关联。

结论

DRD2 基因中的 TaqI_D 和-141C 多态性与抗精神病药引起的 MD 之间存在两种关联;一种与急性静坐不能有关,另一种与迟发性运动障碍有关。这两种多态性先前分别与迟发性运动障碍和急性帕金森病有关。这些结果表明,这些 DRD2 基因变异在抗精神病药引起的 MD 的易感性中的作用是以更普遍或多效性的方式发生的。

相似文献

1
Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.两种 DRD2 基因多态性与年轻白种人患者急性和迟发性抗精神病药物诱发运动障碍的关联。
Psychopharmacology (Berl). 2012 Feb;219(3):727-36. doi: 10.1007/s00213-011-2394-1. Epub 2011 Jul 13.
2
Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.关联研究表明磷脂酰肌醇-4-磷酸-5-激酶对迟发性运动障碍具有保护作用。
Int J Neuropsychopharmacol. 2014 Dec 28;18(6):pyu098. doi: 10.1093/ijnp/pyu098.
3
Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.精神分裂症患者迟发性运动障碍与12种DRD2基因多态性的关联研究。
Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51. doi: 10.1017/S1461145706007152. Epub 2006 Sep 7.
4
[Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].抗精神病药物所致迟发性运动障碍的药物遗传学评估:5-羟色胺2C受体基因以及多巴胺D3变异等位基因(甘氨酸)与锰超氧化物歧化酶野生等位基因(缬氨酸)组合的作用
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):98-102.
5
Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.精神分裂症中多巴胺D2受体基因的三个功能多态性与迟发性运动障碍之间的关联。
Am J Med Genet. 2001 Dec 8;105(8):774-8. doi: 10.1002/ajmg.10045.
6
Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment.长期接受抗精神病药物治疗患者的多巴胺受体DRD1和DRD2基因多态性与精神病理及锥体外系症状
Am J Med Genet B Neuropsychiatr Genet. 2007 Sep 5;144B(6):809-15. doi: 10.1002/ajmg.b.30544.
7
Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective study.长期住院精神科患者的抗精神病药引起的运动障碍与 7 个候选基因中的 45 个标签 SNP:一项前瞻性研究。
PLoS One. 2012;7(12):e50970. doi: 10.1371/journal.pone.0050970. Epub 2012 Dec 4.
8
Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.精神分裂症患者抗精神病药物治疗不良反应与多巴胺D(2)受体基因多态性的关系
Mol Psychiatry. 2002;7(7):695-705. doi: 10.1038/sj.mp.4001054.
9
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.迟发性运动障碍中八个AKT1基因多态性及其与DRD2基因多态性相互作用的遗传学研究。
Schizophr Res. 2008 Dec;106(2-3):248-52. doi: 10.1016/j.schres.2008.08.036. Epub 2008 Oct 5.
10
Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.中国精神分裂症患者多巴胺D3受体基因与迟发性运动障碍
J Neural Transm (Vienna). 2001;108(6):671-7. doi: 10.1007/s007020170044.

引用本文的文献

1
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments.用于抗精神病药物治疗个体化的药物基因组学的临床效用与实施
Pharmaceutics. 2024 Feb 7;16(2):244. doi: 10.3390/pharmaceutics16020244.
2
Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review.单核苷酸多态性作为抗精神病药引起静坐不能的生物标志物:系统评价。
Genes (Basel). 2023 Feb 28;14(3):616. doi: 10.3390/genes14030616.
3
, and Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism.

本文引用的文献

1
Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.GLI2 基因与慢性精神分裂症患者迟发性运动障碍的关联证据。
Mov Disord. 2010 Dec 15;25(16):2809-17. doi: 10.1002/mds.23377.
2
Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs.精神病家族易感性表现为对大麻的差异敏感性的证据:对患者-同胞和同胞-对照配对的分析。
Arch Gen Psychiatry. 2011 Feb;68(2):138-47. doi: 10.1001/archgenpsychiatry.2010.132. Epub 2010 Oct 4.
3
The catechol-O-methyl-transferase gene in tardive dyskinesia.
,以及基因多态性与氟哌啶醇所致帕金森综合征的风险。
Biomedicines. 2022 Dec 13;10(12):3237. doi: 10.3390/biomedicines10123237.
4
Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.与迟发性运动障碍相关的遗传因素:从临床前模型到临床研究
Front Pharmacol. 2022 Jan 24;12:834129. doi: 10.3389/fphar.2021.834129. eCollection 2021.
5
Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients.编码多巴胺受体的候选基因作为精神分裂症患者抗精神病药物所致帕金森症和迟发性运动障碍风险的预测指标
Biomedicines. 2021 Jul 23;9(8):879. doi: 10.3390/biomedicines9080879.
6
Genetics of Common Antipsychotic-Induced Adverse Effects.常见抗精神病药物所致不良反应的遗传学
Mol Neuropsychiatry. 2016 Jul;2(2):61-78. doi: 10.1159/000445802. Epub 2016 May 20.
7
Biomarkers of postoperative delirium and cognitive dysfunction.术后谵妄和认知功能障碍的生物标志物。
Front Aging Neurosci. 2015 Jun 9;7:112. doi: 10.3389/fnagi.2015.00112. eCollection 2015.
8
Psychometric properties of the self-report version of the Quick Inventory of Depressive Symptoms (QIDS-SR₁₆) questionnaire in patients with schizophrenia.精神分裂症患者中抑郁症状快速自评量表(QIDS-SR₁₆)问卷自我报告版本的心理测量学特性。
BMC Psychiatry. 2014 Sep 3;14:247. doi: 10.1186/s12888-014-0247-2.
9
Do we need to consider ethno-cultural variation in the use of atypical antipsychotics for Asian patients with major depressive disorder?对于亚洲患有重度抑郁症的患者,我们是否需要考虑在使用非典型抗精神病药物时考虑种族文化差异?
CNS Drugs. 2013 May;27 Suppl 1:S47-51. doi: 10.1007/s40263-012-0033-y.
10
Predicting the incidence of antipsychotic-induced movement disorders in long-stay patients: A prospective study.预测长期住院患者抗精神病药物所致运动障碍的发生率:一项前瞻性研究。
Epidemiol Psychiatr Sci. 2013 Dec;22(4):375-9. doi: 10.1017/S204579601300019X. Epub 2013 Apr 30.
迟发性运动障碍中的儿茶酚-O-甲基转移酶基因。
World J Biol Psychiatry. 2010 Sep;11(6):803-12. doi: 10.3109/15622975.2010.486043.
4
Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.第二代抗精神病药物与锥体外系副作用:头对头比较的系统评价和荟萃分析。
Schizophr Bull. 2012 Jan;38(1):167-77. doi: 10.1093/schbul/sbq042. Epub 2010 May 31.
5
D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.D2 受体基因变异与抗精神病药物治疗的临床反应:荟萃分析。
Am J Psychiatry. 2010 Jul;167(7):763-72. doi: 10.1176/appi.ajp.2009.09040598. Epub 2010 Mar 1.
6
Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia.西伯利亚俄罗斯精神病住院患者中三种氧化应激酶(GSTP1、SOD2和GPX1)的错义多态性与运动障碍
Hum Psychopharmacol. 2010 Jan;25(1):84-91. doi: 10.1002/hup.1087.
7
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.抗精神病药剂量当量和剂量年:一种比较不同药物暴露的标准化方法。
Biol Psychiatry. 2010 Feb 1;67(3):255-62. doi: 10.1016/j.biopsych.2009.08.040. Epub 2009 Nov 7.
8
Genomewide association study of movement-related adverse antipsychotic effects.全基因组关联研究运动相关的抗精神病药物不良反应。
Biol Psychiatry. 2010 Feb 1;67(3):279-82. doi: 10.1016/j.biopsych.2009.08.036. Epub 2009 Oct 28.
9
Association study of serotonergic gene variants with antipsychotic-induced adverse reactions.血清素能基因变异与抗精神病药物所致不良反应的关联研究。
Psychiatr Genet. 2009 Dec;19(6):305-11. doi: 10.1097/YPG.0b013e3283328dcd.
10
Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.抗精神病药物部分依从性对精神分裂症患者病程的影响:一项综述
Prim Care Companion J Clin Psychiatry. 2009;11(4):147-54. doi: 10.4088/PCC.08r00612.